Skip to main content
An official website of the United States government
Email

Fibrosis at the Crossroads of Tissue Homeostasis and Cancer Workshop

Fibrosis at the Crossroad of Tissue Homeostasis and Cancer Workshop image with a background of an immunofluorescent image of lung desmoplasia

Advances in the area of fibrosis set the stage for an NCI workshop on June 8 - 9, 2026 that explored and discussed the underlying biology of cancer fibrosis (including mechanisms related to immunology, aging, metabolism, and extracellular matrix biology) that, in turn, will help define how fibrotic conditions can lead to increased risk of cancer, how fibrosis can promote cancer progression, and how targeting fibrosis might be coupled to other approaches such as immunotherapies to enhance treatment responses.

Background

The wound healing/injury repair process helps maintain tissue homeostasis but can cause fibrosis if dysregulated. It is becoming increasingly evident that the microenvironment, together with the cancer cell or incipient cancer cells, can function as co-organizers for tumor development and evolution. 

Evidence indicates that chronic disease-linked fibrosis and cancer-associated extracellular matrix (ECM) plays a pivotal role in tumor initiation, progression, and response to therapy. Although fibrosis is obvious only in some tumors (30-60%), most tumors are stiff due to changes in stroma and ECM, suggesting common tissue biological changes. 

Historically, dense and rigid ECM correlates with more aggressive disease across tumor types, yet anti-cancer treatment strategies targeting/disrupting ECM components have led to disappointing (and oftentimes worse) results in the clinic. This is primarily due to our limited knowledge of underlying mechanisms of how fibrosis either suppresses or promotes cancer as a physical structure, the contribution of specific cell types (e.g. tumor cells, fibroblasts, cancer -associated fibroblasts (CAFs), endothelial cells, adipocytes, etc.) to “good ECM” versus “bad ECM,” as well as how these shift during disease progression, leading to a reprogrammed landscape that functions as a selective gatekeeper. 

Recent advances from both within and outside the cancer arena have provided some clues about the role of immune cells in shaping fibrosis and identifying immune suppressive effects of the fibrotic environment. These studies suggest that the immune system plays an integrative role in maintaining tissue homeostasis or contributing to tissue pathology. 

This research at the intersection of cancer and fibrosis helped lead to the development of the Fibrosis at the Crossroads of Tissue Homeostasis and Cancer Workshop.

Documents from the Workshop

Contacts for the Workshop

For additional information about the Workshop, please contact Christina George, Dr. Elizabeth Woodhouse, or Dr. Yin Liu. 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Fibrosis at the Crossroads of Tissue Homeostasis and Cancer Workshop was originally published by the National Cancer Institute.”

Email